Research Article
Potential Canonical Wnt Pathway Activation in High-Grade Astrocytomas
Table 3
Results from multivariate survival analysis. Hazard ratios were adjusted for WHO grade, age at diagnosis, and extent of tumour resection.
| Antigen expression | HR (95% CI) | value |
| β-Catenin |
| In WHO grade II–IV (≤50% versus >50% positive cells) | 1.49 (0.83–2.69) | 0.18 | In WHO grade II (≤50% versus >50% positive cells) | Not determined | Not determined | In WHO grade III (≤50% versus >50% positive cells) | Not determined | Not determined | In WHO grade IV (≤50% versus >50% positive cells) | 1.63 (0.90–2.95) | 0.10 |
| β-Catenin-P654 |
| In WHO grade II–IV (≤5% versus >5% positive cells) | 0.85 (0.63–1.14) | 0.27 | In WHO grade II (≤5% versus >5% positive cells) | 0.37 (0.14–0.96) | 0.04 | In WHO grade III (≤5% versus >5% positive cells) | 0.65 (0.10–4.04) | 0.64 | In WHO grade IV (≤5% versus >5% positive cells) | 0.96 (0.70–1.32) | 0.81 |
|
|